StockData
Incyte Corp logo

Incyte Corp (INCY) stock

INCYNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 13/3091% above fair value
$117.80−1.29 (-1.08%)

Close on Nov 18, 2026Market cap $24.01BP/E 62.7Yield –

Incyte pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Incyte's pe ratio was 15.6× on Nov 11, 2026, against 17.6× a year earlier. Over the last 5 years it ranged from 13.7× to 532.8×, with a median of 21.5×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202615.6×−1.1
2025Dec 31, 202516.7×−476.7
2024Dec 31, 2024493.4×+460.1
2023Dec 29, 202333.2×+12.8
2022Dec 30, 202220.4×−10.0
2021Dec 31, 202130.5×−17.2
2020Apr 30, 202047.6×+0.7
2019Dec 31, 201946.9×−183.2
2017Apr 28, 2017230.2×+101.6
2016Dec 30, 2016128.6×–

More Incyte figures

See a number that looks wrong?